Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study (Q46528410)
Jump to navigation
Jump to search
scientific article published in June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study |
scientific article published in June 2005 |
Statements
1 reference
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study (English)
1 reference
Carmen A Puliafito
1 reference
Stephan Michels
1 reference
Philip J Rosenfeld
1 reference
Erin N Marcus
1 reference
Anna S Venkatraman
1 reference
1 June 2005
1 reference
1 reference
112
1 reference
6
1 reference
1035-1047
1 reference